56 related articles for article (PubMed ID: 7519050)
1. Breakpoints of Burkitt's lymphoma t(8;22) translocations map within a distance of 300 kb downstream of MYC.
Zeidler R; Joos S; Delecluse HJ; Klobeck G; Vuillaume M; Lenoir GM; Bornkamm GW; Lipp M
Genes Chromosomes Cancer; 1994 Apr; 9(4):282-7. PubMed ID: 7519050
[TBL] [Abstract][Full Text] [Related]
2. Activation of c-myc promoter P1 by immunoglobulin kappa gene enhancers in Burkitt lymphoma: functional characterization of the intron enhancer motifs kappaB, E box 1 and E box 2, and of the 3' enhancer motif PU.
Wittekindt NE; Hörtnagel K; Geltinger C; Polack A
Nucleic Acids Res; 2000 Feb; 28(3):800-8. PubMed ID: 10637333
[TBL] [Abstract][Full Text] [Related]
3. A susceptibility locus for classical Hodgkin lymphoma at 8q24 near MYC/PVT1 predicts patient outcome in two independent cohorts.
Ghesquières H; Larrabee BR; Casasnovas O; Maurer MJ; McKay JD; Ansell SM; Montgomery D; Asmann YW; Farrell K; Verney A; Slager SL; Allmer C; Perrot A; Delarue R; Habermann TM; Dupuis J; Link BK; Canioni D; Dogan A; Cozen W; Jarrett RF; Cerhan JR; Salles G
Br J Haematol; 2018 Jan; 180(2):286-290. PubMed ID: 27716907
[No Abstract] [Full Text] [Related]
4. Structure and expression of the c-Myc/Pvt 1 megagene locus.
Siwarski D; Müller U; Andersson J; Notario V; Melchers F; Rolink A; Huppi K
Curr Top Microbiol Immunol; 1997; 224():67-72. PubMed ID: 9308229
[TBL] [Abstract][Full Text] [Related]
5.
Zamani M; Foroughmand AM; Hajjari MR; Bakhshinejad B; Johnson R; Galehdari H
Front Oncol; 2022; 12():954634. PubMed ID: 36052265
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of long non-coding RNA plasmacytoma variant translocation 1 relieves ox-LDL-induced endothelial cell injury through regulating microRNA-30c-5p in atherosclerosis.
Li G; Zong W; Liu L; Wu J; Pang J
Bioengineered; 2022 Feb; 13(2):2791-2802. PubMed ID: 35038974
[TBL] [Abstract][Full Text] [Related]
7. lncRNA PVT1 in the Pathogenesis and Clinical Management of Renal Cell Carcinoma.
Bohosova J; Kubickova A; Slaby O
Biomolecules; 2021 Apr; 11(5):. PubMed ID: 33947142
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA plasmacytoma variant translocation gene 1 promotes epithelial-mesenchymal transition in osteosarcoma.
Xun C; Jiang D; Tian Z; Yunus A; Chen J
J Clin Lab Anal; 2021 Jan; 35(1):e23587. PubMed ID: 32960485
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNAs in ovarian cancer: expression profile and functional spectrum.
Oncul S; Amero P; Rodriguez-Aguayo C; Calin GA; Sood AK; Lopez-Berestein G
RNA Biol; 2020 Nov; 17(11):1523-1534. PubMed ID: 31847695
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA PVT1, a molecular sponge of miR-26b, is involved in the progression of hyperglycemia-induced collagen degradation in human chondrocytes by targeting CTGF/TGF-
Ding LB; Li Y; Liu GY; Li TH; Li F; Guan J; Wang HJ
Innate Immun; 2020 Apr; 26(3):204-214. PubMed ID: 31625803
[TBL] [Abstract][Full Text] [Related]
11. Long Non-Coding RNA Plasmacytoma Variant Translocation 1 (PVT1) Enhances Proliferation, Migration, and Epithelial-Mesenchymal Transition (EMT) of Pituitary Adenoma Cells by Activating β-Catenin, c-Myc, and Cyclin D1 Expression.
Zhang Y; Tan Y; Wang H; Xu M; Xu L
Med Sci Monit; 2019 Oct; 25():7652-7659. PubMed ID: 31604907
[TBL] [Abstract][Full Text] [Related]
12. Autophagy-Modulating Long Non-coding RNAs (LncRNAs) and Their Molecular Events in Cancer.
Islam Khan MZ; Tam SY; Law HKW
Front Genet; 2018; 9():750. PubMed ID: 30693021
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of lncRNAs in lung carcinoma: a meta-analysis.
Fan F; Zhu Z; Gao C; Liu Y; Wang B; Wang Z; Feng J
Oncotarget; 2017 Oct; 8(47):83292-83305. PubMed ID: 29137343
[TBL] [Abstract][Full Text] [Related]
14. LncRNA PVT1 overexpression is a poor prognostic biomarker and regulates migration and invasion in small cell lung cancer.
Huang C; Liu S; Wang H; Zhang Z; Yang Q; Gao F
Am J Transl Res; 2016; 8(11):5025-5034. PubMed ID: 27904703
[TBL] [Abstract][Full Text] [Related]
15. Constitutional t(8;22)(q24;q11.2) that mimics the variant Burkitt-type translocation in Philadelphia chromosome-positive chronic myeloid leukemia.
Kawamoto S; Yamamoto K; Toyoda M; Yakushijin K; Matsuoka H; Minami H
Int J Hematol; 2017 Feb; 105(2):226-229. PubMed ID: 27686674
[TBL] [Abstract][Full Text] [Related]
16. PVT1: a rising star among oncogenic long noncoding RNAs.
Colombo T; Farina L; Macino G; Paci P
Biomed Res Int; 2015; 2015():304208. PubMed ID: 25883951
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer.
Yang YR; Zang SZ; Zhong CL; Li YX; Zhao SS; Feng XJ
Int J Clin Exp Pathol; 2014; 7(10):6929-35. PubMed ID: 25400777
[TBL] [Abstract][Full Text] [Related]
18. Translocations at 8q24 juxtapose MYC with genes that harbor superenhancers resulting in overexpression and poor prognosis in myeloma patients.
Walker BA; Wardell CP; Brioli A; Boyle E; Kaiser MF; Begum DB; Dahir NB; Johnson DC; Ross FM; Davies FE; Morgan GJ
Blood Cancer J; 2014 Mar; 4(3):e191. PubMed ID: 24632883
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNAs in haematological malignancies.
Garitano-Trojaola A; Agirre X; Prósper F; Fortes P
Int J Mol Sci; 2013 Jul; 14(8):15386-422. PubMed ID: 23887658
[TBL] [Abstract][Full Text] [Related]
20. Genetic variants associated with increased risk of malignant pleural mesothelioma: a genome-wide association study.
Matullo G; Guarrera S; Betti M; Fiorito G; Ferrante D; Voglino F; Cadby G; Di Gaetano C; Rosa F; Russo A; Hirvonen A; Casalone E; Tunesi S; Padoan M; Giordano M; Aspesi A; Casadio C; Ardissone F; Ruffini E; Betta PG; Libener R; Guaschino R; Piccolini E; Neri M; Musk AW; de Klerk NH; Hui J; Beilby J; James AL; Creaney J; Robinson BW; Mukherjee S; Palmer LJ; Mirabelli D; Ugolini D; Bonassi S; Magnani C; Dianzani I
PLoS One; 2013; 8(4):e61253. PubMed ID: 23626673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
